These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 30637614)
21. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions. Stoll AC; Kemp CJ; Patterson JR; Howe JW; Steece-Collier K; Luk KC; Sortwell CE; Benskey MJ Neurobiol Dis; 2024 Feb; 191():106411. PubMed ID: 38228253 [TBL] [Abstract][Full Text] [Related]
22. LRRK2 modifies α-syn pathology and spread in mouse models and human neurons. Bieri G; Brahic M; Bousset L; Couthouis J; Kramer NJ; Ma R; Nakayama L; Monbureau M; Defensor E; Schüle B; Shamloo M; Melki R; Gitler AD Acta Neuropathol; 2019 Jun; 137(6):961-980. PubMed ID: 30927072 [TBL] [Abstract][Full Text] [Related]
23. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease. McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553 [TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective. Yi S; Wang L; Wang H; Ho MS; Zhang S Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080 [TBL] [Abstract][Full Text] [Related]
25. Molecular events underlying the cell-to-cell transmission of α-synuclein. Choi YR; Park SJ; Park SM FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736 [TBL] [Abstract][Full Text] [Related]
26. Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis. Kobayashi J; Hasegawa T; Sugeno N; Yoshida S; Akiyama T; Fujimori K; Hatakeyama H; Miki Y; Tomiyama A; Kawata Y; Fukuda M; Kawahata I; Yamakuni T; Ezura M; Kikuchi A; Baba T; Takeda A; Kanzaki M; Wakabayashi K; Okano H; Aoki M FASEB J; 2019 Sep; 33(9):10240-10256. PubMed ID: 31211923 [TBL] [Abstract][Full Text] [Related]
27. α-Synuclein Trafficking in Parkinson's Disease: Insights From Fly and Mouse Models. Cheng J; Lu Q; Song L; Ho MS ASN Neuro; 2018; 10():1759091418812587. PubMed ID: 30482039 [TBL] [Abstract][Full Text] [Related]
28. Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation. Tsunemi T; Ishiguro Y; Yoroisaka A; Valdez C; Miyamoto K; Ishikawa K; Saiki S; Akamatsu W; Hattori N; Krainc D J Neurosci; 2020 Nov; 40(45):8618-8628. PubMed ID: 33046546 [TBL] [Abstract][Full Text] [Related]
29. Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation. Chavarría C; Ivagnes R; Souza JM Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625583 [TBL] [Abstract][Full Text] [Related]
30. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease. Lv QK; Tao KX; Wang XB; Yao XY; Pang MZ; Liu JY; Wang F; Liu CF Inflamm Res; 2023 Mar; 72(3):443-462. PubMed ID: 36598534 [TBL] [Abstract][Full Text] [Related]
31. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease. Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897 [TBL] [Abstract][Full Text] [Related]
33. ⍺-Synuclein levels in Parkinson's disease - Cell types and forms that contribute to pathogenesis. Sagredo GT; Tanglay O; Shahdadpuri S; Fu Y; Halliday GM Exp Neurol; 2024 Sep; 379():114887. PubMed ID: 39009177 [TBL] [Abstract][Full Text] [Related]
34. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease. Miao Y; Meng H Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911 [TBL] [Abstract][Full Text] [Related]
35. Increased Lysosomal Exocytosis Induced by Lysosomal Ca Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622 [TBL] [Abstract][Full Text] [Related]
36. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses. Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100 [TBL] [Abstract][Full Text] [Related]
37. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease. George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995 [TBL] [Abstract][Full Text] [Related]
38. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters. Chistiakov DA; Chistiakov AA Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175 [TBL] [Abstract][Full Text] [Related]
39. Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence. Henriques A; Rouvière L; Giorla E; Farrugia C; El Waly B; Poindron P; Callizot N Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077253 [TBL] [Abstract][Full Text] [Related]
40. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease. Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]